Nutrient Levels Alter Transplant Outcome

Role of Immunonutrient Levels in Preventing Complications After Renal Transplantation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00560014

Enrollment

Registered

2007-11-19

Start date

1997-09-30

Completion date

2005-05-31

Last updated

2007-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Disease

Brief summary

The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.

Interventions

DIETARY_SUPPLEMENTArginine and canola oil

Canola oil 1 tablespoon BID Arginine 9.0grams BID

DIETARY_SUPPLEMENTCoromega and Arginine

Arginine 9.0 grams BID Coromega dose based on weight

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Renal transplant recipient * Appropriate blood samples drawn and analyzed

Design outcomes

Primary

Measure	Time frame
Plasma and red blood cell lipid profiles	Within 1 year
Plasma amino acid profiles	within 1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026